Neurophysiological studies in malignant disease with particular reference to involvement of peripheral nerves

Journal of Neurology

Volumn 249, Issue 6, 2002, Pages 651-661

  Krarup, C ^a   Crone, C ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Chemotherapy; EMG; Neoplasm; Nerve conduction studies; Neuromuscular disorders; Paraneoplastic disorders; Peripheral nerve; Radiation

Indexed keywords

MYELIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CARCINOMA; ELECTRONEUROLOGY; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; METASTASIS; MOTONEURON; NERVE FIBER; NEUROMUSCULAR DISEASE; PERIPHERAL NERVE; PRIORITY JOURNAL; RADIODIAGNOSIS; SENSORY NERVE CELL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHIAL PLEXUS NEUROPATHIES; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; LUMBOSACRAL PLEXUS; MENINGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASMS; NEURAL CONDUCTION; PARANEOPLASTIC POLYNEUROPATHY; RADIOTHERAPY;

EID: 0036087433     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-002-0688-2     Document Type: Article

References (113)

1. Motor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease)
2. Subacute sensory neuropathy: A remote effect of carcinoma
3. Brachial plexus lesions in patients with cancer: 100 Cases
4. Neuromuscular complications of systemic cancer
5. Chemotherapeutic neuropathy
6. A study of the effects upon the motor unit by remote malignancy
7. Paraneoplastic syndromes affecting the central nervous system
8. Anti-Hu autoantibody associated sensory neuropathy/encephalomyelitis: A model of paraneoplastic syndrome
9. Isolated metastases to peripheral nerves. Report of five cases involving the brachial plexus
10. Paraneoplastic brachial plexopathy in a patient with Hodgkin's disease
11. Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG
12. Limb myokymia
13. Brachial plexopathy: Recurrent cancer or radiation?
14. Magnetic resonance imaging in brachial plexopathy of cancer
15. Effects of intraoperative irradiation and intraoperative hyperthermia on canine sciatic nerve: Neurologic and electrophysiologic study
16. Radiation induced lumbosacral plexopathy in gynecologic tumors. Clinical findings and dosimetric analysis
17. Brachial plexus neuropathy following mantle radiotherapy
18. Acute lumbosacral plexopathy during and after preoperative radiotherapy of rectal adenocarcinoma
19. Acute ischemic brachial plexus neuropathy following radiation therapy
20. Ultrastructural morphometric analysis of peripheral nerves after intraoperative irradiation
21. Facial myokymia: Segmental demyelination demonstrated by magnetic stimulation
22. Electrophysiological findings in patients who received radiation therapy over the brachial plexus: A magnetic stimulation study
23. Fasciculation-myokymic activity and prolonged nerve conduction block. A physiopathological relationship in radiation-induced brachial plexopathy
24. Post-irradiation lesions of the caudal roots
25. Plexopathie brachiale post-radique. Blocs de conduction persistants. Décharges myokymiques et crampes
26. Carpet carrier's palsy: Musculocutaneous neuropathy
27. Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia
28. Neuropathies with prolonged conduction block, single and grouped fasciculations, localized limb myokymia
29. Prevention of cisplatin neuro-toxicity with an ACTH(4-9) analogue in patients with ovarian cancer
30. Cisplatin-associated neurotoxicity: Can it be prevented?
31. A randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer
32. Histology and platinum content of sensory ganglia and sural nerves in patients treated with cisplatin and carboplatin: An autopsy study
33. An ultra-structural study of neuronal changes in dorsal root ganglia (DRG) of rats after chronic cisplatin administrations
34. The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro
35. Examination of distal involvement in cisplatin-induced neuropathy in man. An electrophysiological and histological study with particular reference to touch receptor function
36. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol
37. Paclitaxel in platinum-resistant ovarian cancer patients
38. Peripheral neurotoxicity of taxol in patients previously treated with cisplatin
39. Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin
40. Peripheral neurotoxicity induced by docetaxel
41. Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy
42. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies
43. The neuromyopathy of vincristine in the guinea pig. An electrophysiological and pathological study
44. Axonal flow blockade induces alpha-CGRP messenger RNA expression in rat motoneurons
45. Toxic peripheral neuropathies
46. A prospective study of suramin-induced peripheral neuropathy
47. Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia
48. Neurological syndromes associated with carcinoma. The carcinomatous neuromyopathies
49. The remote effects of cancer on the nervous system
50. Paraneoplastic neurologic syndromes
51. Paraneo-plastic peripheral neuropathy
52. Paraneoplastic syndromes of the spinal cord, nerve, and muscle
53. The course and prognosis in some types of carcinomatous neuromyopathy
54. Paraneoplastic sensorimotor neuropathy associated with breast cancer
55. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer
56. Incidence of paramalignant disorders in bronchogenic carcinoma
57. Carcinoid tumor and the nephrotic syndrome: A novel association between neoplasia and glomerular disease
58. Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy
59. Autoimmunity in paraneoplastic neurological syndromes: Closer to the truth?
60. Antibodies to ion channels in paraneoplastic disorders
61. Acquired neuromyotonia: A new autoantibody-mediated neuronal potassium channelopathy
62. Primary sensory neuropathy with muscular changes associated with carcinoma
63. Autoimmunity in paraneoplastic neurological syndromes
64. Paraneoplastic neuropathy
65. Paraneoplastic neurologic syndromes: Pathogenesis and physiopathology
66. Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies
67. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients
68. Autoantibodies associated with peripheral neuropathy
69. Neuronal autoantibody titers in the course of small-cell lung carcinoma and platinum-associated neuropathy
70. Neurologic paraneoplastic syndromes
71. Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies
72. Multiple paraneoplastic syndromes in a patient with antibodies to neuronal nucleoproteins (anti-Hu)
73. Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu- antibodies)
74. Paraneoplastic sensory neuropathy and Purkinje cell antibodies
75. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy
76. The stiff man and stiff man plus syndromes
77. Antiamphiphysin antibodies with small-cell lung carcinoma and paraneoplastic encephalomyelitis
78. Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma
79. Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome
80. Atypical stiffperson syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression
81. The distinctive clinical features of paraneoplastic sensory neuronopathy
82. Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders
83. Paraneoplastic polyneuropathy and subsequent recovery following tumor removal in a dog
84. Clinical and neurophysiologic features in paraneoplastic polyneuropathy
85. Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients
86. Large and small fibre type sensory dysfunction in patients with cancer
87. Peripheral neuropathy and myopathy associated with carcinoma of the lung
88. Peripheral neuropathy of sensorimotor type associated with malignant disease
89. Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies
90. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS Syndrome
91. Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients
92. Waldenström's macroglobulinemia: Clinical features, complications, and management
93. Neuropathy associated with lymphoma
94. Effects of lymphoma on the peripheral nervous system
95. Non-Hodgkin malignant lymphomas and peripheral neuropathies-13 cases
96. Peripheral nerve function in patients with bronchial carcinoma. Comparison with matched controls and effects of treatment
97. Mixed carcinomatous neuropathy in patients with lung cancer and lymphoma
98. A clinicopathological study of the paraneoplastic neuromuscular syndromes associated with lung cancer
99. Electrophysiological investigations into the neurological complications of carcinoma
100. The neuromuscular function in patients with malignant tumours. Electromyographic and histological study
101. Paraneoplastic motor neuron disease
102. Carcinomatous neuromyopathy. 1. Electrophysiological studies. An electrophysiological and immunological study of patients with carcinoma of the lung
103. Indolent anti-Hu-associated paraneoplastic sensory neuropathy
104. Subacute sensory neuronopathy in small cell cancer of the lung. Immunocytochemical study of 2 cases
105. Inflammatory sensory polyganglionopathies
106. Malignancy and sensory neuropathy of unexplained cause: A prospective study of 51 patients
107. Paraneoplastic intestinal pseudo-obstruction, mononeuritis multiplex, and sensory neuropathy/neuronopathy
108. Neuropathy associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma
109. Paraneoplastic vasculitis of nerve: A remote effect of cancer
110. Paraneoplastic vasculitic neuropathy: A treatable neuropathy
111. Paraneoplastic vasculitis of the peripheral nervous system
112. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in Southeastern Netherlands
113. Prognosis in monoclonal gammopathy of undetermined significance